1-2 of 2
Mike Brewster
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Results of the BP22333 Study Demonstrate Non-Inferior Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Administration of Rituximab Compared with Intravenous (IV) Administration As Maintenance Therapy in Patients with Follicular Lymphoma (FL)

Free
Antonio Salar, MD, Irit Avivi, MD, Jean-Francois Larouche, MD, Andrea Janikova, MD, PhD, Juliana Pereira, PhD, Mike Brewster, Olivier Catalani, Christine McIntyre, Pakeeza Sayyed, Andrew Haynes
Journal: Blood
Blood (2012) 120 (21): 1641.
https://doi.org/10.1182/blood.V120.21.1641.1641
Published: 2012
Journal Articles

Subcutaneous Rituximab in Combination with Fludarabine and Cyclophosphamide for Patients with CLL: Initial Results of a Phase Ib Study (SAWYER [BO25341]) Show Non-Inferior Pharmacokinetics and Comparable Safety to That of Intravenous Rituximab

Free
Sarit Assouline, Valeria Buccheri, MD; PhD., Alain Delmer, MD, Gottfried Doelken, MD, Gianluca Gaidano, MD, PhD, Christine McIntyre, Mike Brewster, Florence Hourcade-Potelleret, PhD, Pakeeza Sayyed, Xavier Badoux, MB BS FRACP FRCPA
Journal: Blood
Blood (2012) 120 (21): 1637.
https://doi.org/10.1182/blood.V120.21.1637.1637
Published: 2012